Pascal M Lavoie1, Marie-Pierre Dubé. 1. Child & Family Research Institute, University of British Columbia, Vancouver, Canada. plavoie@cw.bc.ca
Abstract
PURPOSE OF REVIEW: According to recent evidence, susceptibility to bronchopulmonary dysplasia (BPD) in preterm infants is predominantly inherited. The purpose of this review is to discuss current published genetic association studies in light of the accumulated knowledge in genomics. RECENT FINDINGS: Major advances in the development of next-generation genotyping and sequencing platforms, statistical methodologies, inventories of functional outcome of some common genetic polymorphisms and large-scale cataloguing of genetic variability among many of the world's ethnic populations have greatly facilitated the study of polygenic conditions. For BPD, genetic-association studies have primarily focused on components of innate (e.g. first-line) immune and antioxidant defences, mechanisms of vascular and lung remodelling, and surfactant proteins. However, studies have been limited in sample size and therefore fraught with a high probability of false-positive and false-negative associations. Nonetheless, candidate gene associations have indicated some novel biological pathways and provide a conceptual framework for the design of larger, collaborative population-based studies. SUMMARY: Although studies to date have not been able to identify reproducible genetic risk markers for BPD, they have directed us towards new, promising research avenues.
PURPOSE OF REVIEW: According to recent evidence, susceptibility to bronchopulmonary dysplasia (BPD) in preterm infants is predominantly inherited. The purpose of this review is to discuss current published genetic association studies in light of the accumulated knowledge in genomics. RECENT FINDINGS: Major advances in the development of next-generation genotyping and sequencing platforms, statistical methodologies, inventories of functional outcome of some common genetic polymorphisms and large-scale cataloguing of genetic variability among many of the world's ethnic populations have greatly facilitated the study of polygenic conditions. For BPD, genetic-association studies have primarily focused on components of innate (e.g. first-line) immune and antioxidant defences, mechanisms of vascular and lung remodelling, and surfactant proteins. However, studies have been limited in sample size and therefore fraught with a high probability of false-positive and false-negative associations. Nonetheless, candidate gene associations have indicated some novel biological pathways and provide a conceptual framework for the design of larger, collaborative population-based studies. SUMMARY: Although studies to date have not been able to identify reproducible genetic risk markers for BPD, they have directed us towards new, promising research avenues.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio Journal: Proc Natl Acad Sci U S A Date: 2009-05-27 Impact factor: 11.205
Authors: M E Avery; W H Tooley; J B Keller; S S Hurd; M H Bryan; R B Cotton; M F Epstein; P M Fitzhardinge; C B Hansen; T N Hansen Journal: Pediatrics Date: 1987-01 Impact factor: 7.124
Authors: Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper Journal: Genome Med Date: 2009-01-22 Impact factor: 11.117
Authors: Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt Journal: Am J Respir Crit Care Med Date: 2011-08-11 Impact factor: 21.405
Authors: Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich Journal: Pediatrics Date: 2013-07-29 Impact factor: 7.124
Authors: V Sampath; N P Mulrooney; J S Garland; J He; A L Patel; J D Cohen; P M Simpson; R N Hines Journal: J Perinatol Date: 2013-07-18 Impact factor: 2.521
Authors: Colleen M Bartman; Marta Schiliro; Martin Helan; Y S Prakash; David Linden; Christina Pabelick Journal: FASEB J Date: 2020-08-10 Impact factor: 5.191